000 01496 a2200433 4500
005 20250513160515.0
264 0 _c19990125
008 199901s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/s0960-894x(98)00158-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEgron, D
245 0 0 _aAnti-HIV pronucleotides: decomposition pathways and correlation with biological activities.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cMay 1998
300 _a1045-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-HIV Agents
_xchemistry
650 0 4 _aCell Line
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Design
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aIndicators and Reagents
650 0 4 _aProdrugs
_xchemical synthesis
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThymidine Kinase
_xdeficiency
650 0 4 _aVirus Replication
_xdrug effects
650 0 4 _aZidovudine
_xanalogs & derivatives
700 1 _aLefebvre, I
700 1 _aPérigaud, C
700 1 _aBeltran, T
700 1 _aPompon, A
700 1 _aGosselin, G
700 1 _aAubertin, A M
700 1 _aImbach, J L
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 8
_gno. 9
_gp. 1045-50
856 4 0 _uhttps://doi.org/10.1016/s0960-894x(98)00158-9
_zAvailable from publisher's website
999 _c9834129
_d9834129